Cubic multi-ions-doped Na<sub>2</sub>TiO<sub>3</sub> nanorod-like coatings: Structure-stable, highly efficient platform for ions-exchanged release to immunomodulatory promotion on vascularized bone apposition.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35387170.
- Also identified by DOI 10.1016/j.bioactmat.2022.01.039 and PMC identifier 8961311.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The dissolution-derived release of bioactive ions from ceramic coatings on metallic implants, despite improving osseointegration, renders a concern on the interfacial breakdown of the metal/coating/bone system during long-term service. Consequently, persistent efforts to seek alternative strategies instead of dissolution-derived activation are pressingly carrying out. Inspired by bone mineral containing ions as Ca<sup>2+</sup>, Mg<sup>2+</sup>, Sr<sup>2+</sup> and Zn<sup>2+</sup>, here we hydrothermally grew the quadruple ions co-doped Na<sub>2</sub>TiO<sub>3</sub> nanorod-like coatings. The co-doped ions partially substitute Na<sup>+</sup> in Na<sub>2</sub>TiO<sub>3</sub> <b>,</b> and can be efficiently released from cubic lattice via exchange with Na<sup>+</sup> in fluid rather than dissolution, endowing the coatings superior long-term stability of structure and bond strength. Regulated by the coatings-conditioned extracellular ions, TLR4-NFκB signalling is enhanced to act primarily in macrophages (MΦs) at 6 h while CaSR-PI3K-Akt1 signalling is potentiated to act predominately since 24 h, triggering MΦs in a M1 response early and then in a M2 response to sequentially secrete diverse cytokines. Acting on endothelial and mesenchymal stem cells with the released ions and cytokines, the immunomodulatory coatings greatly promote Type-H (CD31<sup>hi</sup>Emcn<sup>hi</sup>) angiogenesis and osteogenesis <i>in vitro</i> and <i>in vivo</i>, providing new insights into orchestrating insoluble ceramics-coated implants for early vascularized osseointegration in combination with long-term fixation to bone.